Tag: Investigational New Drug Application
May 16, 2019
Cue Biopharma Announces FDA Acceptance of IND for Lead Immuno-oncology Candidate CUE-101
Cue Biopharma (NASDAQ:CUE) has announced that the US Food and Drug Administration (FDA) has accepted Cue Biopharma’s investigational new drug... April 11, 2019
Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat
Albireo Pharma (NASDAQ:ALBO) has announced that its investigational new drug application (IND) cleared the 30-day review from the US Food...
December 3, 2018
4 Gene Therapy Companies to Watch
What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
July 2, 2018
4 Top Pharma Stocks on the TSX of Q2 2018
As investors look ahead to the remainder of 2018, we've put together a list of the top-gaining pharmaceutical stocks on... June 7, 2018
MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere
MannKind (Nasdaq:MNKD) announced that it has completed a Phase 1 clinical study of Treprostinil Technosphere (TreT) under an Investigational New...
May 24, 2018
Medicenna Receives Amendment to Revamp Clinical Trial
The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co.... May 10, 2018